

MicroRNA (miRNA) Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global microRNA (miRNA) market is projected to reach USD 2.3 billion by 2027, exhibiting a CAGR of 10.5% during the forecast period. The market is primarily driven by the increasing prevalence of chronic diseases and the advancements in miRNA-based therapeutics. North America holds the largest market share. Request
◍ Thermofisher Scientific (Life Technologies)
◍ Agilent Technologies
◍ Merck KGaA
◍ QIAGEN (Exiqon)
◍ NanoString Technologies, Inc.
◍ Dharmacon (Horizon Discovery Group)
◍ Synlogic
◍ GeneCopoeia, Inc.
◍ New England Biolabs
◍ Quantabio
◍ NanoString Technologies, Inc.
◍ BioGenex
◍ SeqMatic LLC
The MicroRNA (miRNA) market is highly competitive with key players such as Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon, Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, BioGenex, and SeqMatic LLC. These companies offer innovative products and solutions for miRNA research, diagnostics, and therapeutics, contributing to market growth.
- Thermofisher Scientific (Life Technologies), Agilent Technologies, and QIAGEN are leading players in the miRNA market, offering a wide range of products and services for miRNA research and diagnostics.
- NanoString Technologies, Inc. provides advanced technologies for miRNA profiling and analysis, aiding researchers in understanding miRNA function and regulation.
- Dharmacon (Horizon Discovery Group) offers tools for miRNA functional studies, enabling researchers to investigate the role of miRNA in various biological processes.
- Synlogic is focused on developing miRNA-based Request Sample Report
◍ Cancer
◍ Infectious Diseases
◍ Immunological Disorder
◍ Cardiovascular Disease
◍ Neurological Disease
◍ Others
◍ Sample collection
◍ miRNA cDNA Synthesis
◍ Profiling & Purification
◍ Detection
◍ Functional Studies